News & Analysis on Clinical Trial Services & Contract Research And Development
ABPI, Haseeb Ahmad
By Ben Hargreaves
- Last updated on
The Association of the British Pharmaceutical Industry (ABPI) has made Haseeb Ahmad its president, which he will hold alongside his role as MD of Novartis Pharmaceuticals’ UK, Ireland, and Nordics business.
According the ABPI, his responsibilities will be to “promote innovation and collaboration with the NHS and [UK] government, which will not only improve outcomes for patients but also boost the UK economy.”
Ahmad is currently two years into his role at Novartis, joining the company from MSD, known as Merck in the US and Canada, where he spent seven years and was tasked with the role of MD for Greece, Cyprus and Malta. In addition, he held various positions at Schering-Plough for close to eight years.
Ahmad said of his appointment, “The pharmaceutical industry, Government and the NHS must work together to ensure that patients can access innovative therapies and that we deliver the kind of healthcare that all of us in the UK deserve.”